SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Suraksha Diagnostic Ltd

BSE: 544293 NSE: SURAKSHA ISIN: INE877V01027
  |   Sector:  Healthcare   |   Industry:  Hospital & Healthcare Services

Snapshot

Q.1 Which industry/sub-sector does Suraksha Diagnostic Ltd belong to?
Suraksha Diagnostic Ltd belongs to the Healthcare sector, operating specifically within the Hospital & Healthcare Services segment.
Q.2 Is Suraksha Diagnostic Ltd a good quality company?
Suraksha Diagnostic Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Suraksha Diagnostic Ltd undervalued or overvalued?
Suraksha Diagnostic Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Suraksha Diagnostic Ltd a good buy now?
Suraksha Diagnostic Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd revenue growth is 15.3% for FY-2025 , which is above its 5 year CAGR of 9.9% , indicating faster growth.
Q.2 Gross Profit margin of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Gross profit margin which is the profit after deduction of direct costs, is 30.4% for FY-2025 , which is above its 5 year median of 21.6% , indicating increasing margins.
Q.3 Operating Profit Margin of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 32.6% for FY-2025 , which is above its 5 year median of 24.64% indicating increasing margins.
Q.4 Net Profit Margin of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Net Profit Margin is 12.29% for FY-2025 , is above with its 5 year median of 10.57%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 30.4 21.6
Operating Profit Margin 32.6 24.64
Net Profit Margin 12.29 10.57
Q.5 Return on Asset of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Return on Asset is 9.78%, which is above its 5 year historical median of 7.96%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Return on equity is 15.93% for FY-2025 , which is above its historical median of 13.93%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Return on capital employed is 24.92% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Cash conversion cycle is -3 days, above its historical median of -13 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.8 0.8
ROE 15.93 13.93
ROCE 24.92 22.65
Cash Conversion Cycle -3 days -13 days
Q.9 Debt to Equity ratio of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Debt-to-Equity ratio is 0.03 , which is lower with the industry average of 0.22 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd Debt to cash flow from operations is 0.09 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Suraksha Diagnostic Ltd?
Promoters hold 49.10% of the Suraksha Diagnostic Ltd, with 0.10% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Suraksha Diagnostic Ltd vs industry peers?
Suraksha Diagnostic Ltd revenue CAGR is 9.86% , compared to the industry median CAGR of 1.49% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 252.1 144
Gross Profit 76.6 8.2
Operating Profit 82 8.4
Net Profit 31 5
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.8 0.73
ROE 15.93 13.88
ROCE 24.92 17.77
Cash Conversion Cycle (days) -3.04 2

Valuation & price assessment

Q.1 Stock return of Suraksha Diagnostic Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -5.26% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - -5.3%
Q.3 Valuation ratios of Suraksha Diagnostic Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 44.02 53.98 79.71
Price to Book 6.17 0.00 3.54
Price to Sales 4.98 6.82 4.37
EV to EBITDA 15.25 20.02 18.04

Check more companies

1. Aster DM Healthcare
2. Global Health
3. Krishna Inst.Medi
4. Dr. Lal Pathlabs
5. Dr. Agarwals Health
6. RainbowChildrenS Med
7. Vijaya Diagnostic
8. Metropolis Health.
9. Park Medi World
10. HealthcareGlobal
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×